Optimizing the exercise prescription for depression: the search for biomarkers of response
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
There is growing support for the efficacy of exercise interventions for the treatment of individuals who present with mild-to-moderate depression. The variability in treatment response across studies and individuals suggests that the efficacy of exercise for depression will be most optimal when prescribed to individuals who are most prone to respond. The present article reviews contemporary theoretical accounts and recent empirical data pointing to neuroinflammatory states and neurotrophin production as possible biomarkers of the antidepressant response to exercise. The larger exercise and depression literatures provide justification for elevated levels of pro-inflammatory cytokines and deficits in BDNF production as putative matching variables. Although there is some empirical support for these hypotheses, it is clear that this research warrants replication and extension. We offer a few suggestions for future research in this emerging area.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Cooney, G. M., Dwan, K., Greig, C. A., Lawlor, D. A., Rimer, J., Waugh, F. R., McMurdo, M., & Mead, G. E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004366.pub6 · Cited by 1,834
Decreased serum brain-derived neurotrophic factor levels in major depressed patients
Karege, F., Perret, G., Bondolfi, G., Schwald, M., Bertschy, G., & Aubry, J.-M. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00005-7 · Cited by 1,232 · cited 1×
“Indeed, depressed patients have lower peripheral BDNF concentrations relative to their non-depressed counterparts [44,45] and these BDNF levels appear to normalize with successful antidepressant treatment [46].”
BackgroundExercise treatment for depression
Dunn, A. L., Trivedi, M. H., Kampert, J. B., Clark, C. G., & Chambliss, H. O. (2005) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2004.09.003 · Cited by 1,208
Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Stewart, J. W., Nierenberg, A. A., Thase, M. E., Ritz, L., Biggs, M. M., Warden, D., Luther, J. F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052963 · Cited by 1,033 · cited 1×
“Toups and Trivedi [1] discussed the need to identify characteristics for antidepressant medication matching as only a little over a third of patients seeking antidepressant medication treatment achieve remission with their first two treatment steps, and nearly a third of all patients only achieve minimal or no improve…”
BackgroundLiu, Y., Ho, R. C.-M., & Mak, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.003 · Cited by 948
A meta-analytic review of the effects of exercise on brain-derived neurotrophic factor
Szuhany, K. L., Bugatti, M., & Otto, M. W. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.10.003 · Cited by 909
Molendijk, M. L., Spinhoven, P., Polak, M., Bus, B. A. A., Penninx, B. W. J. H., & Elzinga, B. M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.105 · Cited by 702
Exercise Interventions for Mental Health: A Quantitative and Qualitative Review.
Stathopoulou, G., Powers, M. B., Berry, A. C., Smits, J. A. J., & Otto, M. W. (2006) · Clinical Psychology: Science and Practice · doi:10.1111/j.1468-2850.2006.00021.x · Cited by 663 · cited 1×
“In addition, trials that include follow-up assessments up to 12-months indicate that the benefits of exercise may outlast those observed with medication treatments [7].”
BackgroundSelf-citationPolyakova, M., Stuke, K., Schuemberg, K., Mueller, K., Schoenknecht, P., & Schroeter, M. L. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.044 · Cited by 488 · cited 1×
“Indeed, depressed patients have lower peripheral BDNF concentrations relative to their non-depressed counterparts [44,45] and these BDNF levels appear to normalize with successful antidepressant treatment [46].”
BackgroundPhysical exercise intervention in depressive disorders: Meta‐analysis and systematic review
Josefsson, T., Lindwall, M., & Archer, T. (2014) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/sms.12050 · Cited by 483 · cited 1×
“Several randomized controlled trials have supported the efficacy of exercise interventions to alleviate symptoms of mild-to-moderate depression to a degree comparable to other evidence-based treatments, including medications and cognitive behavior therapy [4,5].”
BackgroundKohut, M. L., McCann, D. A., Russell, D. W., Konopka, D. N., Cunnick, J. E., Franke, W. D., Castillo, M. C., Reighard, A. E., & Vanderah, E. (2006) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.12.002 · Cited by 436
Heyman, E., Gamelin, F.-X., Goekint, M., Piscitelli, F., Roelands, B., Leclair, E., Di Marzo, V., & Meeusen, R. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.09.017 · Cited by 427 · cited 1×
“shown to increase the synthesis, release, and expression of BDNF as well as other relevant growth factors [31,49,50,51 ,52 ].”
BackgroundBiological mechanisms underlying the role of physical fitness in health and resilience
Silverman, M. N., & Deuster, P. A. (2014) · Interface Focus · doi:10.1098/rsfs.2014.0040 · Cited by 416
Exercise and the treatment of depression: A review of the exercise program variables
Stanton, R., & Reaburn, P. (2014) · Journal of Science and Medicine in Sport · doi:10.1016/j.jsams.2013.03.010 · Cited by 410
Evidence for prospective associations among depression and obesity in population‐based studies
Faith, M. S., Butryn, M., Wadden, T. A., Fabricatore, A., Nguyen, A. M., & Heymsfield, S. B. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00843.x · Cited by 340 · cited 1×
“and is often associated with depression [16,17], it is important to note the observed IL-6 elevations appear to be specific to the state of depression rather than the high levels of body mass index across many study samples [18].”
BackgroundRimer, J., Dwan, K., Lawlor, D. A., Greig, C. A., McMurdo, M., Morley, W., & Mead, G. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004366.pub5 · Cited by 330
Depressive-like behavior induced by tumor necrosis factor-α in mice
Kaster, M. P., Gadotti, V. M., Calixto, J. B., Santos, A. R. S., & Rodrigues, A. L. S. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.018 · Cited by 294
Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder
Eller, T., Vasar, V., Shlik, J., & Maron, E. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.09.015 · Cited by 290
Hiles, S. A., Baker, A. L., de Malmanche, T., & Attia, J. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.001 · Cited by 274
Mota-Pereira, J., Silverio, J., Carvalho, S., Ribeiro, J. C., Fonte, D., & Ramos, J. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.02.005 · Cited by 257 · cited 1×
“Additionally, there is some— however limited—evidence suggesting that exercise may be useful for treating patients with “treatment-resistant” depression [6].”
BackgroundDhabhar, F. S., Burke, H. M., Epel, E. S., Mellon, S. H., Rosser, R., Reus, V. I., & Wolkowitz, O. M. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.05.010 · Cited by 225 · cited 1×
“Along with the elevated levels of proinflammatory cytokines among depressed individuals, several studies show lower than average levels of anti-inflammatory cytokines such as Interleukin-10 (IL-10) [19] and a lack of correlation between IL-10 and IL-6 that typically is present [20], suggesting there is a dysregulation…”
BackgroundAnterior Cingulate Activation and Error Processing During Interferon-Alpha Treatment
Capuron, L., Pagnoni, G., Demetrashvili, M., Woolwine, B. J., Nemeroff, C. B., Berns, G. S., & Miller, A. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.033 · Cited by 222 · cited 1×
“Moreover, there are several findings suggesting that administration of Interferon-alpha (IFN-alpha; increases IL-6 and TNF-alpha signaling) induces, along with depressed mood and what is sometimes referred to as “sickness behavior” [22–24], pathophysiological states similar to those found in medically healthy depresse…”
BackgroundZhao, G., Ford, E. S., Li, C., Tsai, J., Dhingra, S., & Balluz, L. S. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-130 · Cited by 214 · cited 1×
“and is often associated with depression [16,17], it is important to note the observed IL-6 elevations appear to be specific to the state of depression rather than the high levels of body mass index across many study samples [18].”
BackgroundRaison, C. L., Borisov, A. S., Woolwine, B. J., Massung, B., Vogt, G., & Miller, A. H. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.58 · Cited by 183
Prefrontal cortical hypometabolism during low-dose interferon alpha treatment
Juengling, F. D., Ebert, D., Gut, O., Engelbrecht, M. A., Rasenack, J., Nitzsche, E. U., Bauer, J., & Lieb, K. (2000) · Psychopharmacology · doi:10.1007/s002130000549 · Cited by 149
Neuroendocrine-immune interactions and responses to exercise
Fragala, M. S., Kraemer, W. J., Denegar, C. R., Maresh, C. M., Mastro, A. M., & Volek, J. S. (2011) · Sports Medicine · doi:10.2165/11590430-000000000-00000 · Cited by 145
BDNF genotype moderates the relation between physical activity and depressive symptoms.
Mata, J., Thompson, R. J., & Gotlib, I. H. (2010) · Health Psychology · doi:10.1037/a0017261 · Cited by 119
Effects of serum brain derived neurotrophic factor on exercise augmentation treatment of depression.
Toups, M. S. P., Greer, T. L., Kurian, B. T., Grannemann, B. D., Carmody, T. J., Huebinger, R., Rethorst, C., & Trivedi, M. H. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.05.002 · Cited by 85
Kenis, G., Prickaerts, J., van Os, J., Koek, G. H., Robaeys, G., Steinbusch, H. W. M., & Wichers, M. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000830 · Cited by 58
Cited by
Kandola, A., Ashdown-Franks, G., Hendrikse, J., Sabiston, C. M., & Stubbs, B. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.040 · Cited by 1,309
Neurobiological effects of exercise on major depressive disorder: A systematic review
Schuch, F. B., Deslandes, A. C., Stubbs, B., Gosmann, N. P., Silva, C. T. B. D., & Fleck, M. P. D. A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.11.012 · Cited by 279
Smits, J. A. J., Zvolensky, M. J., Davis, M. L., Rosenfield, D., Marcus, B. H., Church, T. S., Powers, M. B., Frierson, G. M., Otto, M. W., Hopkins, L. B., et al. (2016) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000264 · Cited by 103
“As one example, given that emerging research implicates improved immune function in the antidepressant effects of exercise (47), it maybe advisable to assess and model immune system functioning in exercise-smoking work.”
BackgroundSelf-citationThe effects of exercise on transdiagnostic treatment targets: A meta-analytic review
Jacquart, J., Dutcher, C. D., Freeman, S. Z., Stein, A. T., Dinh, M., Carl, E., & Smits, J. A. J. (2019) · Behaviour Research and Therapy · doi:10.1016/j.brat.2018.11.007 · Cited by 56
Self-citation
Metadata
- Authors
- Medina, J. L., Jacquart, J., & Smits, J. A.
- Venue
- Current Opinion in Psychology
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 4
- Pages
- 43-47
- ISSN
- 2352-250X (ISSN-L)
- OpenAlex
- W1983806269
- Cited by
- 30
- References
- 31
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.